Intermittent hypoxia minimizes harmful nitric oxide formation in canine heart subjected to coronary occlusion and reperfusion.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000473:pathology; D054059:Coronary Occlusion / Q000473:pathology*; D004285:Dogs; D006321:Heart / Q000502:physiology*; D006331:Heart Diseases; D000860:Hypoxia; D015425:Myocardial Reperfusion; D009206:Myocardium / Q000473:pathology*; D009569:Nitric Oxide / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D015427:Reperfusion Injury; D012306:Risk; D013481:Superoxides; D013997:Time Factors
D013481:Superoxides; D009569:Nitric Oxide; D052250:Nitric Oxide Synthase Type III